U.S. Vaccine Names

Sort by Vaccine Name, Abbreviation, Trade Name, or Manufacturer

Sort the following chart by clicking on the column heading you wish to see sorted. You will know the current sorting selection as that heading will show a darkened arrow and the other headings will show their arrows in gray. The direction of the arrow (up or down) reflects the direction the column is sorted.

See also:

Print-friendly version of this chart[4 pages] can be found in the Epidemiology of Vaccine-Preventable Diseases textbook.
ACIP’s recommended vaccines list

Vaccine	TradeName	Abbreviation	Manufacturer	Type/Route	Approved	Comments
Adenovirus	Adenovirus Type 4 & Type 7		Barr Labs Inc.	Live Viral / Oral (tablets)	2011	Approved for military populations 17 through 50 years of age.
Anthrax	BioThrax^®	AVA	Emergent BioSolutions	Inactivated Bacterial / IM	1970
Cholera	Vaxchora^®		PaxVax	Live Bacterial / Oral	2016	Age range 18 through 64 years.
DT	Generic	DT	sanofi	Inactivated Bacterial Toxoids / IM	1978	Age range 6 months through 6 years.
DTaP	Daptacel^®	DTaP	sanofi	Inactivated Bacterial / IM	2002	Age range 6 months through 6 years.
DTaP	Infanrix^®	DTaP	GlaxoSmithKline	Inactivated Bacterial / IM	1997	Age range 6 months through 6 years.
DTaP, Polio	Kinrix^®	DTaP-IPV	GlaxoSmithKline	Inactivated Bacterial & Viral / IM	2008	Licensed for 5th (DTaP) and 4th (IPV) booster at 4-6 years
DTaP, Polio	Quadracel™	DTaP-IPV	sanofi	Inactivated Bacterial & Viral / IM	2015	Approved for 5th (DTaP) and 4th (IPV) booster at 4-6 years
DTaP, hepatitis B, Polio	Pediarix^®	DTaP-HepB-IPV	GlaxoSmithKline	Inactivated Bacterial & Viral / IM	2002	Age range 6 months through 6 years.
DTaP, Polio, Haemophilus influenzae type b	Pentacel^®	DTaP-IPV/Hib	sanofi	Inactivated Bacterial & Viral / IM	2008	Age range 6 months through 4 years.
Haemophilus influenzae type b (Hib)	ActHIB^®	Hib	sanofi	Inactivated Bacterial / IM	1993	PRP-T. Polysaccharide conjugate (tetanus toxoid carrier). 3-dose primary series.
Haemophilus influenzae type b (Hib)	Hiberix^®	Hib	GlaxoSmithKline	Inactivated Bacterial / IM	2009	PRP-T. Polysaccharide conjugate (tetanus toxoid carrier). 3-dose primary series.
Haemophilus influenzae type b (Hib)	PedvaxHIB^®	Hib	Merck	Inactivated Bacterial / IM	1989	PRP-OMP. Polysaccharide conjugate (mening. protein carrier). 2-dose primary series.
Haemophilus influenzae type b. Meningococcal	MenHibrix^®	Hib-MenCY	GlaxoSmithKline	Inactivated Bacterial / IM	2012	Polysaccharide conjugate Hib and meningococcal serogroups C and Y (tetanus toxoid carrier)
Hepatitis A	Havrix^®	HepA	GlaxoSmithKline	Inactivated Viral / IM	1995	Pediatric (≤18 and adult formulations. Pediatric = 720 EL.U., 0.5mL Adult = 1,140 EL.U., 1.0mL Minimum age = 1 year.
Hepatitis A	Vaqta^®	HepA	Merck	Inactivated Viral / IM	1996	Pediatric (≤18 and adult formulations. Pediatric = 25 U. 0.5mL Adult = 50 U. 1.0mL Minimum age = 1 year.
Hepatitis B	Engerix-B^®	HepB	GlaxoSmithKline	Inactivated Viral / IM	1989	Pediatric (≤19 and adult formulations. Pediatric formulation not licensed for adults.
Hepatitis B	Recombivax HB^®	HepB	Merck	Inactivated Viral / IM	1986	Pediatric (≤19, adult, and dialysis formulations. Two pediatric doses may be substituted for an adult dose.
Hepatitis A, Hepatitis B	Twinrix^®	HepA-HepB	GlaxoSmithKline	Inactivated Viral / IM	2001	Pediatric dose of HepA + adult dose of HepB. Minimum age = 18 years. 3-dose routine series. (4-dose alternate schedule for rapid protection.)
Herpes Zoster (Shingles)	Zostavax	HZV	Merck	Live Attenuated Viral / SC	2006	Minimum age = 50 years.
Human Papillomavirus	Gardasil^®	HPV4	Merck	Inactivated Viral / IM	2006	Quadrivalent (types 6, 11, 16, 18). Approved for males and females 9 through 26 years.
Human Papillomavirus	Gardasil^® 9	9vHPV	Merck	Inactivated Viral / IM	2014	9-valent (types 6, 11, 16, 18, 31, 33. 45, 52, 58). Approved for males and females 9 through 26 years.
Influenza	Afluria^®	IIV3 IIV4	Seqirus	Inactivated Viral / IM	2007 2016	Minimum ages: 5 years (trivalent) 18 years (quadrivalent)
Influenza	Fluad^®	IIV3	Sequiris	Inactivated Viral / IM	2015	Adjuvented Minimum age = 65 years
Influenza	Fluarix^®	IIV3 IIV4	GlaxoSmithKline	Inactivated Viral / IM	2005 2012	Minimum age = 3 years. Trivalent & quadrivalent formulations.
Influenza	Flublok^®	RIV3 RIV4	Protein Sciences	Inactivated Viral / IM	2013	Recombinant protein vaccine. Minimum age = 18 years
Influenza	Flucelvax^®	ccIIV3 ccIIV4	Seqirus	Inactivated Viral / IM	2012 2016	Cell culture vaccine. Minimum age = 4 years
Influenza	FluLaval^®	IIV3 IIV4	GlaxoSmithKline	Inactivated Viral / IM	2006 2013	Minimum age = 6 months. Trivalent & quadrivalent formulations
Influenza	FluMist^®	LAIV4	Medimmune	Live Attenuated Viral / Intranasal (spray)	2003	Age range = 2 through 49 years. Quadrivalent
Influenza	Fluvirin^®	IIV3	Seqirus	Inactivated Viral / IM	1988	Minimum age = 4 years.
Influenza	Fluzone^®	IIV3 IIV4	sanofi	Inactivated Viral / IM	1980 2013	Minimum age = 6 months
Influenza	Fluzone High- Dose^®	IIV3	sanofi	Inactivated Viral / IM	2009	Minimum age = 65 years
Influenza	Fluzone Intradermal^®	IIV4	sanofi	Inactivated Viral / Intradermal	2014	Age range 18 through 64 years. 0.1 mL dose.
Japanese encephalitis	Ixiaro^®	JE	Valneva	Inactivated Viral / IM	2009	Minimum age = 2 months 2-dose series.
Measles, Mumps, Rubella	M-M-R^® II	MMR	Merck	Live Attenuated Viral / SC	1978 (First MMR – 1971)	Minimum age = 12 months
Measles, Mumps, Rubella, Varicella	ProQuad^®	MMRV	Merck	Live Attenuated Viral / SC	2005	Age range = 1 through 12 years.
Meningococcal	Menomune^®	MPSV4	sanofi	Inactivated Bacterial / SC	1981	Polysaccharide, containing serogroups A, C, W, & Y. Minimum age = 2 years.
Meningococcal	Menactra^®	MCV4 MenACWY	sanofi	Inactivated Bacterial / IM	2005	Polysaccharide conjugate (diphtheria toxoid carrier), containing serogroups A, C, W, & Y. Age Range 9 months through 55 years
Meningococcal	Menveo^®	MCV4 MenACWY	Novartis	Inactivated Bacterial / IM	2010	Polysaccharide conjugate (diphtheria toxoid carrier), containing serogroups A, C, W, & Y. Age Range 2 months through 55 years
Meningococcal	Trumenba^®	MenB	Pfizer	Recombinant Bacterial / IM	2014	Age range 10 through 25 years
Meningococcal	Bexsero^®	MenB	GlaxoSmithKline	Recombinant Bacterial / IM	2015	Age range 10 through 25 years
Pneumococcal	Pneumovax^® 23	PPSV23	Merck	Inactivated Bacterial / SC or IM	1983	Polysaccharide (23 strains). Minimum age = 2 years.
Pneumococcal	Prevnar 13^®	PCV13	Wyeth / Pfizer	Inactivated Bacterial / IM	2010 (PCV7 – 2000)	Polysaccharide conjugate (diphtheria protein carrier, 13 strains). Minimum age = 6 weeks
Polio	Ipol^®	IPV	sanofi	Inactivated Viral / SC or IM	1990 (IPV-1955)	Trivalent, Types 1, 2, & 3. Minimum age = 6 weeks
Rabies	Imovax^® Rabies		sanofi	Inactivated Viral / IM	1980	All ages
Rabies	RabAvert^®		Novartis	Inactivated Viral / IM	1997	All ages
Rotavirus	RotaTeq^®	RV5	Merck	Live Viral / Oral (liquid)	2006	Pentavalent. First dose between 6 weeks and 14 weeks 6 days; complete 3-dose series by 8 months 0 days.
Rotavirus	Rotarix^®	RV1	GlaxoSmithKline	Live Viral / Oral (liquid)	2008	Monovalent. First dose between 6 weeks and 14 weeks 6 days; complete 2-dose series by 8 months 0 days.
Tetanus, (reduced) Diphtheria	(Generic)	Td	Massachusetts Biological Labs	Inactivated Bacterial Toxoids / IM	1967	Adult formulation (age 7 and older).
Tetanus, (reduced) Diphtheria	Tenivac ^®	Td	sanofi	Inactivated Bacterial Toxoids / IM	2003	Adult formulation (age 7 and older).
Tetanus, (reduced) Diphtheria, (reduced) Pertussis	Adacel^®	Tdap	sanofi	Inactivated Bacterial / IM	2005	Tetanus and diphtheria toxoids & acellular pertussis vaccine. Age range 10 through 64 years.
Tetanus, (reduced) Diphtheria, (reduced) Pertussis	Boostrix^®	Tdap	GlaxoSmithKline	Inactivated Bacterial / IM	2005	Tetanus & diphtheria toxoids & pertussis vaccine. Minimum age = 10 years.
Typhoid	Typhim Vi^®		sanofi	Inactivated Bacterial / IM	1994	Polysaccharide Minimum age = 2 years
Typhoid	Vivotif^®		PaxVax	Live Attenuated Bacterial / Oral (capsules)	1989	Ty21a strain Minimum age = 6 years
Varicella	Varivax^®	VAR	Merck	Live Attenuated Viral / SC	1995	Minimum age = 12 months.
Vaccinia (Smallpox)	ACAM2000^®		sanofi	Live Attenuated Viral / Percutaneous	2007	All ages
Yellow Fever	YF-Vax^®	YF	sanofi	Live Attenuated Viral / SC	1978	Minimum age = 9 months.

Showing 1 to 57 of 57 entries

Abbreviations
The abbreviations on this table (Column 3) were standardized jointly by staff of the Centers for Disease Control and Prevention, ACIP Work Groups, the editor of the Morbidity and Mortality Weekly Report (MMWR), the editor of Epidemiology and Prevention of Vaccine-Preventable Diseases (the Pink Book), ACIP members, and liaison organizations to the ACIP.

These abbreviations are intended to provide a uniform approach to vaccine references used in ACIP Recommendations and Policy Notes published in the MMWR, the Pink Book, and the American Academy of Pediatrics Red Book, and in the U.S. immunization schedules for children, adolescents, and adults.

In descriptions of combination vaccines, dash (-) indicates: products in which the active components are supplied in their final (combined) form by the manufacturer; slash ( / ) indicates: products in which active components must be mixed by the user.

Top of Page

Page last reviewed: May 11, 2017
Page last updated: May 11, 2017
Content source:
- National Center for Immunization and Respiratory Diseases

Vaccines & Immunizations

U.S. Vaccine Names

Sort by Vaccine Name, Abbreviation, Trade Name, or Manufacturer

File Formats Help: